346 related articles for article (PubMed ID: 15743893)
1. Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis.
De Bels D; Garcia-Filoso A; Jeanmaire M; Préseau T; Miendje Deyi VY; Devriendt J
J Antimicrob Chemother; 2005 May; 55(5):812-3. PubMed ID: 15743893
[No Abstract] [Full Text] [Related]
2. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Howden BP; Ward PB; Charles PG; Korman TM; Fuller A; du Cros P; Grabsch EA; Roberts SA; Robson J; Read K; Bak N; Hurley J; Johnson PD; Morris AJ; Mayall BC; Grayson ML
Clin Infect Dis; 2004 Feb; 38(4):521-8. PubMed ID: 14765345
[TBL] [Abstract][Full Text] [Related]
4. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
[No Abstract] [Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
Salerno D; Vahid B; Marik PE
Ann Thorac Surg; 2007 May; 83(5):1888-91. PubMed ID: 17462428
[TBL] [Abstract][Full Text] [Related]
6. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
7. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
8. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
9. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.
Stevens DL; Wallace RJ; Hamilton SM; Bryant AE
Clin Infect Dis; 2006 Mar; 42(5):729-30. PubMed ID: 16447124
[No Abstract] [Full Text] [Related]
10. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
[TBL] [Abstract][Full Text] [Related]
11. Haematological safety of long-term therapy with linezolid.
Garazzino S; De Rosa FG; Bargiacchi O; Audagnotto S; Maiello A; Di Perri G
Int J Antimicrob Agents; 2007 Apr; 29(4):480-3. PubMed ID: 17317112
[No Abstract] [Full Text] [Related]
12. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Ruiz ME; Guerrero IC; Tuazon CU
Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
[TBL] [Abstract][Full Text] [Related]
13. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
14. Experience with linezolid therapy in children with osteoarticular infections.
Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
[TBL] [Abstract][Full Text] [Related]
15. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
[No Abstract] [Full Text] [Related]
16. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Beeck VO; Dhif N; Philipp J; De Bels D
J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
[No Abstract] [Full Text] [Related]
17. Co-emergence of linezolid-resistant Staphylococcus aureus and Enterococcus faecium in a patient with methicillin-resistant S. aureus pneumonic sepsis.
An D; Lee MY; Jeong TD; Sung H; Kim MN; Hong SB
Diagn Microbiol Infect Dis; 2011 Feb; 69(2):232-3. PubMed ID: 21251573
[No Abstract] [Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus endocarditis in an extremely low-birth-weight infant treated with linezolid.
Sung TJ; Kim HM; Kim MJ
Clin Pediatr (Phila); 2008 Jun; 47(5):504-6. PubMed ID: 18509151
[No Abstract] [Full Text] [Related]
19. Linezolid-associated toxic optic neuropathy: a report of 2 cases.
Lee E; Burger S; Shah J; Melton C; Mullen M; Warren F; Press R
Clin Infect Dis; 2003 Nov; 37(10):1389-91. PubMed ID: 14583875
[TBL] [Abstract][Full Text] [Related]
20. Linezolid to decrease length of stay in the hospital for patients with methicillin-resistant Staphylococcus aureus infection.
Siegel RE
Clin Infect Dis; 2003 Jan; 36(1):124; author reply 124-5. PubMed ID: 12491215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
